MONARCH MEDICAL TECHNOLOGIES
About MONARCH MEDICAL TECHNOLOGIES
Monarch Medical Technologies is a digital health company specializing in inpatient glycemic management, now operating as a Glooko Company. Their flagship product, the FDA-cleared EndoTool® Glucose Management System, is designed to replace traditional manual insulin dosing protocols with individualized, predictive, and computer-based applications. This system aims to deliver safer and more effective glucose control for both critical and non-critical patients, significantly reducing the incidence of severe hypoglycemia and hyperglycemia.
The EndoTool platform provides personalized insulin dose recommendations for both intravenous and subcutaneous delivery, integrating seamlessly with major Electronic Medical Record (EMR) systems. It leverages advanced scientific principles and sophisticated algorithms that account for patient-specific factors, such as renal function, which influence insulin response. This approach enhances patient outcomes by ensuring precision dosing and improving patient safety and operational efficiency within healthcare enterprises.
As a Glooko Company, Monarch Medical Technologies continues its mission to deliver precision, safety, and confidence in insulin dosing, now extending its leadership beyond hospital walls by connecting with Glooko’s outpatient platform to support people with diabetes seamlessly across the continuum of care.
Focus Areas
Business Intelligence
| Key Investors | Eigen Capital, Pfizer Hospital, Semler Scientific |
| Partnerships | Glooko (acquisition), Voluntis (prior partnership) |
| Acquisitions | Acquired by Glooko (September 23, 2025); EndoTool business previously acquired by Hospira (2008) and then by Eigen Capital (2012) |
| Technology | EndoTool Glucose Management System (EndoTool IV, EndoTool SubQ), predictive computer-based applications, individualized management tools, AI and cloud-based solutions focus, model predictive control technology, EMR integration |
| FDA Clearances | At least 6 cleared products (estimated) |
What Physicians Need to Know
For physicians, Monarch Medical Technologies' EndoTool system offers several key advantages. It significantly enhances patient safety by virtually eliminating severe hypoglycemia and reducing hyperglycemia, crucial for improving outcomes in hospitalized patients. The personalized insulin dosing, which considers individual patient factors like renal function, provides precise and tailored treatment, even for complex cases such as DKA, HHS, and gestational diabetes. The clinical decision support streamlines workflows, reduces the burden of manual calculations, and provides real-time recommendations, allowing more time for direct patient care. Furthermore, the platform supports compliance with new CMS electronic clinical quality measures for severe hypoglycemia and hyperglycemia, aligning with national priorities for diabetes care and impacting reimbursement. The system's proven track record, backed by clinical evidence and guided by a Clinical Advisory Board of leading experts, instills confidence in its efficacy and safety.
EndoTool is designed for seamless integration with any Electronic Health Record (EHR) and Electronic Medical Record (EMR) system. It utilizes HL7 protocols for reliable interfacing, enabling smooth bi-directional data exchange for treatments, lab values, patient information, and provider orders. The system also employs HTML-based integration for application access, allowing clinicians to launch EndoTool with a single click from within a patient's chart, automatically populating patient details and values, thereby optimizing workflow and minimizing data entry.
What the Web Says
Monarch Medical Technologies, now a Glooko Company, is known for its EndoTool Glucose Management System, which provides patient-specific insulin dosing in hospital environments. The product is generally well-regarded by hospital customers for improving glycemic management, reducing hypoglycemia, and enhancing nurse workflows. However, employer reviews indicate a mixed internal culture with high turnover and concerns about management support and job security.
Overall: MixedStrengths
- EndoTool reduces hypoglycemia and improves insulin dosing safety.
- Clinical evidence supports major reductions in severe inpatient hypoglycemia with EndoTool.
- Hospital case studies highlight improved workflow standardization and nurse confidence.
- EndoTool helps reduce average length of hospital stay for patients with diabetes.
- The system seamlessly integrates with EHR systems, reducing duplicate documentation.
- Offers work-from-home options and travel for some roles.
Limitations
- High employee turnover and frequent CEO changes.
- Management often does not support employees, leading to fear for job security.
- Some employees report a lack of helpfulness among colleagues, possibly due to fear of job displacement.
- Lack of public G2, Capterra, or Gartner Peer Insights ratings for their specific product (EndoTool) limits third-party comparison data.
- No patient-facing mobile app for EndoTool, which may limit its fit for programs expecting direct consumer engagement.
- Enterprise rollout complexity and protocol change management can be adoption hurdles.
Based on reviews from: Indeed.com, Monarch Medical Technologies Website, RFP.wiki, AWS Marketplace
Last updated: 2026-07-18
Videos
News, demos, and interviews about MONARCH MEDICAL TECHNOLOGIES.
Videos load interactively. If none appear, search YouTube for MONARCH MEDICAL TECHNOLOGIES →
Press & Coverage
Frequently Asked Questions
Comparisons
Related Companies
CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]
Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]
OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]
Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]
MedTalk AI is an Australian-based healthcare AI company focused on streamlining clinical documentation for physicians and other healthcare professionals. The company’s flagship product is an ambient AI medical scribe that listens to real clinical conversations and converts them into structured, accurate notes in real-time. This technology aims to free clinicians from the burden of manual […]
allergoSMART is a healthcare AI company that offers the world’s first AI-based complete solution for personalized mite allergen avoidance. The company’s system, allergoSMART, provides a unique AI digital solution for individuals with dust mite allergies, combining targeted prevention and treatment through comprehensive home environment optimization. [3] It integrates symptom tracking, telemedicine, and air purification into […]